| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
In Oman, the prevalence of hepatitis B (HBV) infection is 5.8%, with
2.8–7.1% HBV carriers. Hepatitis C (HCV) prevalence among Omanis is
0.41%. A total of 2917 human immunodeficiency virus (HIV) infections
were notified among Omanis by 2017. This study was performed as there
was no data on the prevalence of HIV, HBV and HCV in sickle cell
disease (SCD) patients from Oman.
Material and Methods
|Table 1. Demographic, clinical, laboratory and radiological parameters in the SCD patient cohort (n=1000)|
|Figure 1. HCV genotypes in SCD patients (n=1000).|